Barchuk, Anton
Tursun-zade, Rustam
Nazarova, Ekaterina
Komarov, Yuri
Tyurina, Ekaterina
Tumanova, Yulia
Belyaev, Alexey
Znaor, Ariana
Article History
Received: 12 February 2023
Accepted: 8 October 2023
First Online: 18 October 2023
Declarations
:
: This research is part of a collaborative effort of the NN Petrov National Medical Research Center of Oncology in Saint Petersburg, Russia, the European University at St. Petersburg, Saint-Petersburg, Russia, and the International Agency for Research on Cancer, Lyon, France. According to the Russian national regulation (The Order of the Ministry of Health N420 12/23/96), anonymised cancer registry data from the NWFD are collected and maintained in NRMCO for various purposes, including epidemiological analyses and international cooperation. All data analysis was performed at NN Petrov National Medical Research Center of Oncology. The requirement for ethical approval and consent to participate is waived according to Russian legislation on registry-based research in which the subjects are not in contact or subject to intervention. The ethics committee: Ethics Committee of the NN Petrov National Medical Research Center of Oncology. All data analysis was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Anton Barchuk reports personal fees from AstraZeneca, MSD, and Biocad outside the submitted work. Other authors have no conflict of interest or competing interests related to the submitted work.